NASDAQ:PRPH ProPhase Labs Q1 2026 Earnings Report $0.12 +0.00 (+0.17%) As of 05/14/2026 03:39 PM Eastern ProfileEarnings HistoryForecast ProPhase Labs EPS ResultsActual EPSN/AConsensus EPS -$1.20Beat/MissN/AOne Year Ago EPSN/AProPhase Labs Revenue ResultsActual RevenueN/AExpected Revenue$9.67 millionBeat/MissN/AYoY Revenue GrowthN/AProPhase Labs Announcement DetailsQuarterQ1 2026Date5/18/2026TimeBefore Market OpensConference Call DateTuesday, May 19, 2026Conference Call Time10:00AM ETConference Call ResourcesEarnings HistoryCompany Profile ProPhase Labs Earnings HeadlinesProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections PlatformApril 15, 2026 | globenewswire.comProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections ActivityMarch 18, 2026 | finance.yahoo.com$30 stock to buy before Starlink goes public (WATCH NOW!)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.May 15 at 1:00 AM | Paradigm Press (Ad)ProPhase Labs Explores Strategic Options for BE-Smart TestFebruary 13, 2026 | tipranks.comProPhase Labs, Inc.: ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart and Advances Crown Medical Collections InitiativeFebruary 3, 2026 | finanznachrichten.deProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections InitiativeFebruary 3, 2026 | finance.yahoo.comSee More ProPhase Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ProPhase Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ProPhase Labs and other key companies, straight to your email. Email Address About ProPhase LabsProPhase Labs (NASDAQ:PRPH) is a U.S.-based specialty health sciences company that develops, manufactures and markets a range of diagnostic and therapeutic products. The company’s operations span infectious disease testing services, over-the-counter remedies and contract manufacturing for pharmaceutical and consumer health clients. ProPhase Labs leverages both in-house production facilities and distribution networks to bring targeted solutions to market. In its diagnostics division, ProPhase Labs offers laboratory-based testing for respiratory and infectious diseases, employing molecular and immunoassay technologies. The company’s lab services cater to hospitals, clinics and physician practices by providing timely, accurate results that support patient care and public health monitoring. On the therapeutic side, ProPhase Labs markets a portfolio of over-the-counter products designed to relieve symptoms of cold and flu, including nasal inhalers and throat sprays, alongside branded disinfectants and personal care items. ProPhase Labs also provides contract manufacturing and packaging services for third-party health and wellness companies, overseeing formulation, sterile filling and quality-control testing within its U.S. facilities. Through these integrated offerings, the company serves a broad domestic customer base in the healthcare, retail and institutional markets. Management continues to focus on expanding its diagnostic test menu and consumer product lines, leveraging regulatory expertise and manufacturing capabilities to support future growth.View ProPhase Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles YETI Rallies After Earnings Beat and Raised OutlookAeluma's Post-Earnings Dip Creates a Buying OpportunityCisco’s Vertical Rally May Still Be in the Early InningsKarman: Defense Darling's Outlook Strengthens After 40% DropHow the 3 Leading Quantum Firms Stack Up After Q1 EarningsNebius Upside Expands as AI Feedback Loop IntensifiesOklo Stock Could Be Ready for Another Massive Run Upcoming Earnings Baidu (5/18/2026)Palo Alto Networks (5/19/2026)Home Depot (5/19/2026)Keysight Technologies (5/19/2026)Analog Devices (5/20/2026)Intuit (5/20/2026)NVIDIA (5/20/2026)Lowe's Companies (5/20/2026)Medtronic (5/20/2026)Target (5/20/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
